Horizon Pharma has settled a lawsuit with prescription benefits manager Express Scripts related to disputed drug rebates.
Horizon Pharma USA, a Lake Forest, Ill.-based subsidiary of the Irish drugmaker, will pay $65 million to settle a lawsuit over $166.2 million in rebate payments that St. Louis-based Express Scripts said it was owed from Horizon, according to regulatory filings. The settlement comes after Horizon countersued Express Scripts, contesting the amount owed and alleging a breach of contract by the PBM.
The suit relates to rebates for Duexis, Rayos and Vimovo, which are some of Horizon’s most popular drugs and are used in rheumatoid arthritis and osteoporosis, among other diseases. Neither party will admit any fault or wrongdoing in the settlement.
By Adam Rubenfire at ModernHealthcare.com